This announcement is a separate document:
维康药业：关于对深圳证券交易所2023年年报问询函的回复公告
Zhejiang Wecome Pharmaceutical: Announcement on the reply to the inquiry letter of the 2023 annual report of the Shenzhen Stock Exchange.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.